Advair

Novartis gives up on Advair generic, leaving Mylan as sole competitor
BioPharma Dive
Wed, 01/29/20 - 11:52 pm
Novartis
generics
Advair
Mylan
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Pharmaforum
Wed, 11/27/19 - 10:47 am
Hikma
FDA
generics
GSK
Advair
asthma
COPD
Biopharma's biggest sellers – the oldies that just keep giving
Evaluate Pharma
Sat, 08/17/19 - 01:38 pm
Amgen
Enbrel
patents
biologics
Advair
Zantac
Liptor
Plavix
Novartis' asthma triplet beats GSK's Advair in phase 2 trial
Fierce Pharma
Wed, 05/22/19 - 10:51 am
Novartis
asthma
QVM149
GSK
Advair
clinical trials
Mylan's Advair generic pressures GSK with strong launch
BioPharma Dive
Fri, 03/8/19 - 04:09 pm
GSK
Mylan
generics
Advair
Wixela Inhub
Mylan launches Advair generic at 70% discount in US
Pharmaforum
Wed, 02/13/19 - 10:13 am
Mylan
GSK
Advair
generics
Mylan’s Generic Advair Breathes New Life into Asthma Market
Xtalks
Tue, 02/5/19 - 10:03 am
Mylan
GSK
Advair
generics
FDA
asthma
Wixela Inhub
Mylan finally crosses the finish line with long-awaited generic of GlaxoSmithKline's Advair
Fierce Pharma
Wed, 01/30/19 - 06:58 pm
Mylan
GSK
FDA
Advair
generics
Wixela Inhub
GlaxoSmithKline expands API production for COPD inhalers as Advair sales wither
Fierce Pharma
Tue, 10/23/18 - 01:26 pm
GSK
COPD
Advair
GSK wins yet another reprieve for blockbuster Advair franchise as Mylan is hit (again) with a CRL
Endpoints
Thu, 06/14/18 - 09:59 am
Mylan
FDA
Advair
GSK
complete response letter
FDA Denies Mylan Petition on Advair Generics
RAPS.org
Thu, 05/10/18 - 11:04 pm
FDA
Mylan Labs
generics
Advair
Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die
Yahoo/Bloomberg
Fri, 05/4/18 - 11:26 am
GSK
Advair
asthma
generics
Good news, Glaxo: Novartis' Advair copy definitely won't see the market this year
Fierce Pharma
Fri, 04/20/18 - 10:00 am
Novartis
GSK
Advair
asthma
GSK wins new reprieve as Hikma's generic Advair delayed again
Yahoo/Reuters
Tue, 03/13/18 - 11:45 am
GSK
Hikma
generics
Advair
Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge
Endpoints
Tue, 03/13/18 - 10:15 am
FDA
Advair
AstraZeneca
Imfinzi
clinical trials
No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging
Endpoints
Thu, 02/8/18 - 11:18 am
GSK
R&D
Pharma CEOs
Emma Walmsley
Advair
Novartis
Sandoz
Gilead Sciences
HIV
FDA rejects Novartis’ Advair generic, leaving GSK without rival
Drug Delivery Business News
Thu, 02/8/18 - 09:17 am
FDA
Novartis
Advair
generics
GSK
Sandoz
GSK seeks to protect Advair through GBP1.2bn acquisition of Vectura
GoinPharma
Sat, 01/13/18 - 01:59 pm
GSK
Advair
Vectura
M&A
Novartis looks to poach Advair patients with positive Ultibro switching data
Fierce Pharma
Mon, 11/27/17 - 10:42 am
Novartis
Advair
Ultibro Breezhaler
GSK
COPD
With Advair copies looming, GSK keeps focus on new drugs
Biopharma Dive
Wed, 10/25/17 - 10:12 pm
GSK
earnings
Advair
Trelegy Ellipta
Shingrix

Pages